BRIEF published on 06/11/2024 at 09:05, 2 years 4 months ago Medincell Joins Euronext Tech Leaders Index Innovation Tech Sector Investor Visibility Medincell Euronext Tech Leaders
BRIEF published on 06/11/2024 at 09:05, 2 years 4 months ago Medincell rejoint l'indice Euronext Tech Leaders Innovation Secteur Technologique Visibilité Des Investisseurs Médine Leaders Technologiques D'Euronext
PRESS RELEASE published on 06/11/2024 at 09:00, 2 years 4 months ago Inside Information / Other news releases Medincell joins Euronext Tech Leaders, gaining access to a broad investor base and support services. CEO Christophe Douat highlights the company's growth and tech innovation leadership Tech Sector Financial Strategy Investor Base Medincell Euronext Tech Leaders
PRESS RELEASE published on 06/11/2024 at 09:00, 2 years 4 months ago Informations privilégiées / Autres communiqués Medincell rejoint l’indice Euronext Tech Leaders, accédant à un vaste écosystème et renforçant sa visibilité auprès d'investisseurs internationaux. La technologie BEPO® innovante de Medincell est reconnue Croissance Innovation Medincell Euronext Tech Leaders BEPO®
BRIEF published on 05/10/2024 at 18:05, 2 years 5 months ago Medincell annonce les détails sur le capital et les droits de vote conformément à la réglementation Euronext Paris Droits De Vote Réglementation Financière Capital Social Medincell
BRIEF published on 05/10/2024 at 18:05, 2 years 5 months ago Medincell announces details on capital and voting rights in accordance with regulations Euronext Paris Share Capital Voting Rights Financial Regulation Medincell
PRESS RELEASE published on 05/10/2024 at 18:00, 2 years 5 months ago Informations privilégiées / Autres communiqués Annonce mensuelle des actions et droits de vote de Medincell sur Euronext Paris. Medincell développe des médicaments injectables à action prolongée pour divers domaines thérapeutiques Euronext Paris AMF Biopharmaceutique Medincell Médicaments Injectables
BRIEF published on 05/08/2024 at 12:35, 2 years 5 months ago Résultats Positifs pour l'Essai Phase 3 SOLARIS sur l’Olanzapine Schizophrénie Medincell TEV-‘749 SOLARIS Olanzapine
BRIEF published on 05/08/2024 at 12:35, 2 years 5 months ago Positive Results for the SOLARIS Phase 3 Trial of Olanzapine Schizophrenia Medincell SOLARIS Olanzapine TEV-'749
PRESS RELEASE published on 05/08/2024 at 12:30, 2 years 5 months ago Informations privilégiées / Autres communiqués Les résultats positifs de l'étude de phase 3 SOLARIS démontrent l'efficacité de TV-749, injection sous-cutanée mensuelle pour la schizophrénie par Teva et Medincell Santé Mentale Schizophrénie Medincell TV-749 Teva
Published on 10/10/2026 at 04:45, 1 day 4 hours ago Immutable Holdings and Jorge Masvidal's Gamebred Fighting Championship (FC) Enter Into Definitive Agreement for Proposed Reverse Takeover Transaction and Listing on the TSXV
Published on 10/10/2026 at 02:03, 1 day 7 hours ago BrandPilot AI Announces Closing of Previously Announced Debt Settlement
Published on 10/10/2026 at 02:00, 1 day 7 hours ago Battery X Metals Reports Estimated Driving Range Increase of Approximately 101 Kilometers Following a Single-Electric-Vehicle Performance Evaluation of Next-Generation Patent-Pending Lithium-Ion Battery Rebalancing Technology
Published on 10/09/2026 at 23:00, 1 day 10 hours ago Trans Canada Gold Closes First Tranche of Non-Brokered Private Placement for Gross Proceeds of CDN $2,144,720
Published on 10/09/2026 at 22:15, 1 day 11 hours ago Loop Industries to Host Second Quarter Fiscal 2027 Earnings Conference Call
Published on 10/10/2026 at 16:35, 16 hours 42 minutes ago New Opportunities for Global Cooperation: Kexing Biopharm Shines at CPHI Milan 2026
Published on 10/10/2026 at 16:30, 16 hours 47 minutes ago ZPMC-Built Infrastructure Supports China's First Offshore Wind Project to Deploy 18 MW Turbines at Scale
Published on 10/10/2026 at 10:05, 23 hours 12 minutes ago ONLYOFFICE 10.0 brings AI tools, modular apps, and stronger security to its open-source office suite
Published on 10/09/2026 at 21:24, 1 day 11 hours ago Branicks Group AG: Extraordinary General Meeting does not approve all items on the agenda
Published on 10/09/2026 at 21:17, 1 day 12 hours ago EQS-Adhoc: Branicks Group AG: Agenda topic four at extraordinary general meeting rejected
Published on 10/09/2026 at 19:27, 1 day 13 hours ago Disclosure of transactions in own shares from October 1 to October 9, 2026
Published on 10/09/2026 at 19:27, 1 day 13 hours ago Déclaration hebdomadaire d'opérations effectuées du 1er au 9 octobre 2026
Published on 10/09/2026 at 17:45, 1 day 15 hours ago Déclaration des droits de vote à fin septembre 2026
